[1]
S. N. Tan, A. Ibrahim, M. R. Abdul Razak, M. N. Abdul Azih, and S. H. How, “Intermittent EGFR-TKI Therapy is Associated with Durable Response in Advanced EGFR-Mutant NSCLC: A Case Report”, Malays J Med Health Sci, vol. 19, no. 2, pp. 341–343, Mar. 2023.